A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism

• Published in: Multiple sclerosis and related disorders Vol. 39; p. 101900
• Main Authors: Tomczak, Anna, Su, Elaine, Tugizova, Madina, Carlson, Aaron M., Kipp, Lucas B., Feng, Haojun, Han, May H.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2020
• Subjects: Astroglial autoimmunity; Dementia; GFAP; Immune modulation; Parkinsonism; Parkinsonism; Astroglial autoimmunity; Immune modulation; Dementia; GFAP
• ISSN: 2211-0348; 2211-0356
• DOI: 10.1016/j.msard.2019.101900

•Autoimmune GFAP astrocytopathy is a new autoimmune CNS inflammatory disorder.•We report a case of autoimmune GFAP astrocytopathy presenting with parkinsonism.•Treatment with corticosteroids resulted in clinical and radiographic improvement.•Parkinsonism symptoms were fully resolved after immunomodulatory treatment. Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a newly recognized autoimmune central nervous system (CNS) inflammatory disorder, presenting with an array of neurological symptoms in association with autoantibodies against GFAP, a hallmark protein expressed on astrocytes. Limited knowledge is available on the disease pathogenesis and clinical outcome. Here, we report a case of autoimmune GFAP astrocytopathy presenting with encephalomyelitis and parkinsonism. Our patient was a 66-year old male who experienced progressive somnolence, apathy, anxiety, right arm tremor, urinary retention, progressive weakness, and falls over the course of three months, followed by acute delusional psychosis. His neurologic exam on hospital admission was notable for cognitive impairment, myoclonus, rigidity, right hand action tremor, bradykinesia, shuffling gait, and dysmetria. Cerebrospinal fluid examination showed elevated protein, lymphocytic pleocytosis, and one unique oligoclonal band. Magnetic resonance imaging (MRI) revealed non-specific T2/FLAIR hyperintensities in the brain and longitudinally extensive transverse myelitis in the cervical spine. FDG-PET showed a pattern of brain uptake suspicious for limbic encephalitis. Serum and CSF paraneoplastic panel showed presence of GFAP immunoglobulin G (IgG). Treatment with corticosteroids resulted in clinical and radiographic improvement. However, the patient was treated with anti-CD20 immunotherapy due to steroid-dependence. This case exemplifies the recently described neurologic syndrome of autoimmune GFAP astrocytopathy presenting with encephalomyelitis and parkinsonism, reversed by B lymphocyte depletion.